Zobrazeno 1 - 5
of 5
pro vyhledávání: '"François Planeix"'
Autor:
Christophe Pichon, Tine Kold Olesen, Jean Gogusev, Nicolae Ghinea, François Planeix, Blaise Robin, Xavier Sastre-Garau
Publikováno v:
Reproductive Sciences. 23:885-891
Follicle-stimulating hormone receptor (FSHR) is present on endothelial cells of blood vessels and endometrial glands of the proliferative and secretory endometrium. So far, the expression of FSHR in endometriosis has not been studied. We evaluated FS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e329eab516fd951eae1c0cd10b7792d
https://doi.org/10.1177/1933719115623647
https://doi.org/10.1177/1933719115623647
Autor:
Ronan Crepin, Ario de Marco, François Planeix, Gianluca Veggiani, Sebastian Amigorena, Selma Djender, Franck Perez, Anne Beugnet, Sandrine Moutel, Nicolae Ghinea, Christophe Pichon
Publikováno v:
Biochemical and biophysical research communications. 493(4)
Antibodies are essential reagents that are increasingly used in diagnostics and therapy. Their specificity and capacity to recognize their native antigen are critical characteristics for their in vivo application. Follicle-stimulating hormone recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6fb05617c83f31270c0966927db4b2f
https://pubmed.ncbi.nlm.nih.gov/29017919
https://pubmed.ncbi.nlm.nih.gov/29017919
Autor:
Aurelian Radu, Nicolae Ghinea, Philippe Camparo, Gaëlle Fromont, Martine Antoine, François Planeix, Julie Gonin, Christophe Pichon, Virginie Desestret, Michel Huerre, Ahsan Siraj, Marc Sanson
Publikováno v:
BMC Cancer
BMC Cancer, 2013, 13 (1), pp.246. ⟨10.1186/1471-2407-13-246⟩
BMC Cancer, BioMed Central, 2013, 13 (1), pp.246. ⟨10.1186/1471-2407-13-246⟩
BMC Cancer, 2013, 13 (1), pp.246. ⟨10.1186/1471-2407-13-246⟩
BMC Cancer, BioMed Central, 2013, 13 (1), pp.246. ⟨10.1186/1471-2407-13-246⟩
Background The Follicle Stimulating Hormone receptor (FSHR) is expressed by the vascular endothelium in a wide range of human tumors. It was not determined however if FSHR is present in metastases which are responsible for the terminal illness. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c1103e11369c88cca257416bdfd3d89
https://pubmed.ncbi.nlm.nih.gov/23688201
https://pubmed.ncbi.nlm.nih.gov/23688201
Publikováno v:
Journal of Clinical Oncology. 33:e16035-e16035
e16035 Background: Work from our laboratory shows that FSH-receptor (FSHR) is present in the tumor endothelial cells, most frequently at the periphery of the hormone-naive prostate cancer tissue. H...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bfd35c887969603ea8d5fc61a1aaaa0
https://doi.org/10.1200/jco.2015.33.15_suppl.e16035
https://doi.org/10.1200/jco.2015.33.15_suppl.e16035
Autor:
Nicolae Ghinea, Mohammad-Ahsan Siraj, Jean-Yves Pierga, François Planeix, François-Clément Bidard, Martine Antoine, Xavier Sastre
Publikováno v:
Cancer Research. 74:7-7
Recent data from our laboratory show that the follicle-stimulating hormone receptor (FSHR) is expressed on the endothelial surface of tumor peripheral blood vessels in different types of tumors including breast cancer. The main goal of the present st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47dcf4696d4ade528d076eb69fe97f4f
https://doi.org/10.1158/1538-7445.am2014-7
https://doi.org/10.1158/1538-7445.am2014-7